Health Care & Life Sciences » Biotechnology | Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc. | Ownership

Companies that own Adverum Biotechnologies Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Adage Capital Management LP
4,000,000
6.38%
500,000
0.07%
06/30/2018
Renaissance Technologies LLC
3,387,600
5.4%
-343,977
0.03%
06/30/2018
BlackRock Fund Advisors
3,019,876
4.82%
2,334,457
0%
06/30/2018
The Vanguard Group, Inc.
2,151,696
3.43%
344,225
0%
06/30/2018
Citadel Advisors LLC
2,050,353
3.27%
675,675
0.02%
06/30/2018
Driehaus Capital Management LLC
1,990,096
3.17%
119,157
0.3%
06/30/2018
JPMorgan Investment Management, Inc.
1,815,062
2.9%
505,272
0%
06/30/2018
Highbridge Capital Management LLC
1,661,986
2.65%
-438,014
0.39%
06/30/2018
Dimensional Fund Advisors LP
1,606,407
2.56%
427,215
0%
06/30/2018
Alkeon Capital Management LLC
1,166,684
1.86%
66,931
0.12%
06/30/2018

About Adverum Biotechnologies

View Profile
Address
1035 O'Brien Drive
Menlo Park California 94025
United States
Employees -
Website http://www.adverum.com
Updated 07/08/2019
Adverum Biotechnologies, Inc. is a clinical-stage biotechnology company that engages in the development of novel gene therapies to treat patients with sight-threatening ophthalmic diseases. It focuses on treatment of wet age-related macular degeneration, alpha-1 antitrypsin deficiency, hereditary angioedema, friedreich's ataxia, severe allergy, color vision deficiency, and juvenile x-linked retinoschisis. The company was founded by Mark S.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.